microRNA-421-3p prevents inflammatory response in cerebral ischemia/reperfusion injury through targeting m6A Reader YTHDF1 to inhibit p65 mRNA translation

•miR-421-3p expression decreases during cerebral I/R injury in vivo and in vitro.•Overexpression of miR-421-3p inhibits OGD/R-induced inflammatory response in microglia.•Overexpression of miR-421-3p inhibits OGD/R-induced activation of NF-κB signaling.•miR-421-3p targets YTHDF1 mRNA to inhibit its e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International immunopharmacology 2020-11, Vol.88, p.106937-106937, Article 106937
Hauptverfasser: Zheng, Linbo, Tang, Xialin, Lu, Minyi, Sun, Shuangxi, Xie, Shanshan, Cai, Jun, Zan, Jie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•miR-421-3p expression decreases during cerebral I/R injury in vivo and in vitro.•Overexpression of miR-421-3p inhibits OGD/R-induced inflammatory response in microglia.•Overexpression of miR-421-3p inhibits OGD/R-induced activation of NF-κB signaling.•miR-421-3p targets YTHDF1 mRNA to inhibit its expression.•YTHDF1 recognizes m6A modified p65 mRNA to promote its translation.•miR-421-3p suppresses inflammatory response during cerebral I/R injury through regulating YTHDF1/P65. Ischemic stroke is one of the leading causes of death globally, and inflammation is considered as a vital contributor to the pathophysiology of ischemic stroke. Recently, microRNA-421-3p-derived macrophages is found to promote motor function recovery in spinal cord injury. Here, we explored whether microRNA-421-3p is involved in inflammation responses during cerebral ischemia/reperfusion (I/R) injury and its molecular mechanism. An in vivo experimental animal model of intraluminal middle cerebral artery occlusion/reperfusion (MCAO/R) and in vitro model of microglial subjected to oxygen-glucose deprivation and reoxygenation (OGD/R) were used. The effects of microRNA-421-3p on cerebral I/R injury and its underlying mechanism were detected by quantitative real-time PCR, western blotting, immunofluorescence staining, RNA immunoprecipitation, flow cytometry, luciferase reporter assay, and bioinformatics analysis. We find that microRNA-421-3p is significantly decreased in cerebral I/R injury in vitro and in vivo. Furthermore, overexpression of microRNA-421-3p evidently suppresses pro-inflammatory factor expressions and inhibits NF-κB p65 protein expression and nuclear translocation in BV2 microglia cells treated with OGD/R. However, microRNA-421-3p neither promotes p65 mRNA expression, nor affects p65 mRNA or protein stability. Moreover, we find the m6A ‘reader’ protein YTH domain family protein 1 (YTHDF1) is the specific target of microRNA-421-3p, and YTHDF1 specifically binds to the m6a site of p65 mRNA to promote its translation. microRNA-421-3p prevents inflammatory response in cerebral ischemia/reperfusion injury through targeting YTHDF1 to inhibit p65 mRNA translation. These findings provide novel insights into understanding the molecular pathogenesis of cerebral I/R injury.
ISSN:1567-5769
1878-1705
DOI:10.1016/j.intimp.2020.106937